These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 24075927)

  • 1. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.
    Ernsting MJ; Murakami M; Roy A; Li SD
    J Control Release; 2013 Dec; 172(3):782-94. PubMed ID: 24075927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
    Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
    J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles for tumor targeted therapies and their pharmacokinetics.
    Wang J; Sui M; Fan W
    Curr Drug Metab; 2010 Feb; 11(2):129-41. PubMed ID: 20359289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.
    Ullah R; Wazir J; Khan FU; Diallo MT; Ihsan AU; Mikrani R; Aquib M; Zhou X
    AAPS PharmSciTech; 2020 May; 21(4):132. PubMed ID: 32409932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral drug delivery with nanoparticulate carriers.
    Holback H; Yeo Y
    Pharm Res; 2011 Aug; 28(8):1819-30. PubMed ID: 21213021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery.
    Wang X; Zhang H; Chen X; Wu C; Ding K; Sun G; Luo Y; Xiang D
    Acta Biomater; 2023 Aug; 166():42-68. PubMed ID: 37257574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing Tumor Penetration of Nanomedicines.
    Sun Q; Ojha T; Kiessling F; Lammers T; Shi Y
    Biomacromolecules; 2017 May; 18(5):1449-1459. PubMed ID: 28328191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrier permeation and improved nanomedicine delivery in tumor microenvironments.
    Liu J; Zhang J; Gao Y; Jiang Y; Guan Z; Xie Y; Hu J; Chen J
    Cancer Lett; 2023 May; 562():216166. PubMed ID: 37028698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charge-Switchable nanoparticles to enhance tumor penetration and accumulation.
    Souri M; Golzaryan A; Soltani M
    Eur J Pharm Biopharm; 2024 Jun; 199():114310. PubMed ID: 38705311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral Pharmacokinetics: Challenges to Nanobiomaterials.
    Al-Abd AM; Al-Abbasi FA; Torchilin VP
    Curr Pharm Des; 2015; 21(22):3208-14. PubMed ID: 26027565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in drug delivery systems for enhancing drug penetration into tumors.
    He B; Sui X; Yu B; Wang S; Shen Y; Cong H
    Drug Deliv; 2020 Dec; 27(1):1474-1490. PubMed ID: 33100061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.
    Durymanov MO; Rosenkranz AA; Sobolev AS
    Theranostics; 2015; 5(9):1007-20. PubMed ID: 26155316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The development of novel tumor targeting delivery strategy].
    Gao HL; Jiang XG
    Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tumor microenvironments on targeted delivery of glycol chitosan nanoparticles.
    Yhee JY; Jeon S; Yoon HY; Shim MK; Ko H; Min J; Na JH; Chang H; Han H; Kim JH; Suh M; Lee H; Park JH; Kim K; Kwon IC
    J Control Release; 2017 Dec; 267():223-231. PubMed ID: 28917532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle approaches to combating drug resistance.
    Moon JH; Moxley JW; Zhang P; Cui H
    Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermia and smart drug delivery systems for solid tumor therapy.
    Seynhaeve ALB; Amin M; Haemmerich D; van Rhoon GC; Ten Hagen TLM
    Adv Drug Deliv Rev; 2020; 163-164():125-144. PubMed ID: 32092379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.
    Lucas AT; Price LS; Schorzman A; Zamboni WC
    Nanomedicine (Lond); 2017 Aug; 12(16):2021-2042. PubMed ID: 28745129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril improves tumor nanomedicine delivery by increasing tumor blood perfusion and enlarging endothelial gaps in tumor blood vessels.
    Zhang B; Jiang T; Tuo Y; Jin K; Luo Z; Shi W; Mei H; Hu Y; Pang Z; Jiang X
    Cancer Lett; 2017 Dec; 410():12-19. PubMed ID: 28939029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors.
    Miao L; Lin CM; Huang L
    J Control Release; 2015 Dec; 219():192-204. PubMed ID: 26277065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor heterogeneity and nanoparticle-mediated tumor targeting: the importance of delivery system personalization.
    Swetha KL; Roy A
    Drug Deliv Transl Res; 2018 Oct; 8(5):1508-1526. PubMed ID: 30128797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.